...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rumors starting again

Presently 6 trials being done with various drug cos.  Most interest in TNBC and Prostrate cancer studies, where outcomes are supposed to be be very impressive. Virtual meeting with one partner has been scheduled for this month. 

Share
New Message
Please login to post a reply